Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Sep;188(9):2766-2771.
doi: 10.1002/ajmg.a.62761. Epub 2022 Apr 20.

Late-onset Proteus syndrome with cerebriform connective tissue nevus and subsequent development of intraductal papilloma

Affiliations
Case Reports

Late-onset Proteus syndrome with cerebriform connective tissue nevus and subsequent development of intraductal papilloma

Emily W Modlin et al. Am J Med Genet A. 2022 Sep.

Abstract

Proteus syndrome (PS) is a rare segmental overgrowth disorder caused by a mosaic activating variant in AKT1. The features of PS are often not present at birth but develop during the first few years of life. We describe a 55-year-old female, whose first symptom of overgrowth, a cerebriform connective tissue nevus, occurred at 19 years of age. We report the identification of the AKT1 c.49G > A p.(Glu17Lys) variant in this progressive lesion, the bony overgrowth, and recurrence after surgical intervention. In the sixth decade of life, this individual developed intraductal papillomas within her right breast which were confirmed to contain the same activating AKT1 variant as the connective tissue nevus. While similar neoplasms have been described in an individual with Proteus syndrome, none has been evaluated for the presence of the AKT1 variant. The tumor also contained two likely pathogenic variants in PIK3R1, c.1392_1403dupTAGATTATATGA p.(Asp464_Tyr467dup) and c.1728_1730delGAG p.(Arg577del). The finding of additional genetic variation putatively affecting the PI3K/AKT pathway in the neoplastic tissue may provide preliminary evidence of a molecular mechanism for tumorigenesis in PS. The late onset of symptoms and molecular characterization of the breast tumor expand the clinical spectrum of this rare disorder.

Keywords: Proteus syndrome; connective tissue nevus; intraductal papilloma; overgrowth.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
Skin and bone overgrowth in bilateral feet. Photography of the left foot showing progression of CCTN from (a) 48 years of age immediately prior to third resection, (b) to 50 years of age and (c) 55 years of age. At 55 years of age radiography of (d) the right foot showed overgrowth of the tarsal and navicular bones and (e) right foot hallux valgus deformity with metatarsal overgrowth
FIGURE 2
FIGURE 2
Hematoxylin and eosin stained section of breast core biopsy with epithelial and stromal hyperplasia

Similar articles

Cited by

References

    1. Beachkofsky TM, Sapp JC, Biesecker LG, & Darling TN (2010). Progressive overgrowth of the cerebriform connective tissue nevus in patients with Proteus syndrome. Journal of the American Academy of Dermatology, 63(5), 799–804. 10.1016/j.jaad.2009.12.012 - DOI - PMC - PubMed
    1. Biesecker L (2006). The challenges of Proteus syndrome: Diagnosis and management. European Journal of Human Genetics, 14(11), 1151–1157. 10.1038/sj.ejhg.5201638 - DOI - PubMed
    1. Buser A, Lindhurst MJ, Kondolf HC, Yourick MR, Keppler-Noreuil KM, Sapp JC, & Biesecker LG (2020). Allelic heterogeneity of Proteus syndrome. Cold Spring Harbor Molecular Case Studies, 6(3), a005181. 10.1101/mcs.a005181 - DOI - PMC - PubMed
    1. Cheung LW, Yu S, Zhang D, Li J, Ng PK, Panupinthu N, Mitra S, Ju Z, Yu Q, Liang H, Hawke DH, Lu Y, Broaddus RR, & Mills GB (2014). Naturally occurring neomorphic PIK3R1 mutations activate the MAPK pathway, dictating therapeutic response to MAPK pathway inhibitors. Cancer Cell, 26(4), 479–494. 10.1016/j.ccell.2014.08.017 - DOI - PMC - PubMed
    1. Çiloğlu S, Duran A, Önsal E, Yiğit K, & Onamay B (2015). Recurrence of isolated plantar cerebriform collagenoma. Turkish Journal of Dermatology, 9, 205–206. 10.4274/tdd.2246 - DOI

Publication types

Substances

Supplementary concepts